COGT
Price
$7.00
Change
-$0.53 (-7.04%)
Updated
Mar 3, 04:59 PM (EDT)
Capitalization
857.29M
71 days until earnings call
SLNO
Price
$45.81
Change
-$3.01 (-6.17%)
Updated
Mar 3, 04:59 PM (EDT)
Capitalization
2.1B
71 days until earnings call
Ad is loading...

COGT vs SLNO

Header iconCOGT vs SLNO Comparison
Open Charts COGT vs SLNOBanner chart's image
Cogent Biosciences
Price$7.00
Change-$0.53 (-7.04%)
Volume$28.7K
Capitalization857.29M
Soleno Therapeutics
Price$45.81
Change-$3.01 (-6.17%)
Volume$24.37K
Capitalization2.1B
COGT vs SLNO Comparison Chart
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. SLNO commentary
Mar 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a StrongBuy and SLNO is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Mar 04, 2025
Stock price -- (COGT: $7.53 vs. SLNO: $48.82)
Brand notoriety: COGT and SLNO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 126% vs. SLNO: 165%
Market capitalization -- COGT: $857.29M vs. SLNO: $2.1B
COGT [@Biotechnology] is valued at $857.29M. SLNO’s [@Biotechnology] market capitalization is $2.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $398.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.49B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileSLNO’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • SLNO’s FA Score: 0 green, 5 red.
According to our system of comparison, COGT is a better buy in the long-term than SLNO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 4 TA indicator(s) are bullish while SLNO’s TA Score has 5 bullish TA indicator(s).

  • COGT’s TA Score: 4 bullish, 6 bearish.
  • SLNO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SLNO is a better buy in the short-term than COGT.

Price Growth

COGT (@Biotechnology) experienced а -5.87% price change this week, while SLNO (@Biotechnology) price change was +5.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.35%. For the same industry, the average monthly price growth was -9.54%, and the average quarterly price growth was -4.71%.

Reported Earning Dates

COGT is expected to report earnings on May 13, 2025.

SLNO is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-5.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLNO($2.1B) has a higher market cap than COGT($857M). SLNO YTD gains are higher at: 8.610 vs. COGT (-3.462). SLNO has higher annual earnings (EBITDA): -136.5M vs. COGT (-256.4M). COGT has more cash in the bank: 336M vs. SLNO (257M). SLNO has less debt than COGT: SLNO (3.03M) vs COGT (17.8M). COGT (0) and SLNO (0) have equivalent revenues.
COGTSLNOCOGT / SLNO
Capitalization857M2.1B41%
EBITDA-256.4M-136.5M188%
Gain YTD-3.4628.610-40%
P/E RatioN/AN/A-
Revenue00-
Total Cash336M257M131%
Total Debt17.8M3.03M588%
FUNDAMENTALS RATINGS
COGT vs SLNO: Fundamental Ratings
COGT
SLNO
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
99
Overvalued
PROFIT vs RISK RATING
1..100
65100
SMR RATING
1..100
9696
PRICE GROWTH RATING
1..100
6557
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

COGT's Valuation (82) in the Miscellaneous industry is in the same range as SLNO (99) in the Medical Specialties industry. This means that COGT’s stock grew similarly to SLNO’s over the last 12 months.

COGT's Profit vs Risk Rating (65) in the Miscellaneous industry is somewhat better than the same rating for SLNO (100) in the Medical Specialties industry. This means that COGT’s stock grew somewhat faster than SLNO’s over the last 12 months.

COGT's SMR Rating (96) in the Miscellaneous industry is in the same range as SLNO (96) in the Medical Specialties industry. This means that COGT’s stock grew similarly to SLNO’s over the last 12 months.

SLNO's Price Growth Rating (57) in the Medical Specialties industry is in the same range as COGT (65) in the Miscellaneous industry. This means that SLNO’s stock grew similarly to COGT’s over the last 12 months.

SLNO's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as COGT (100) in the Miscellaneous industry. This means that SLNO’s stock grew similarly to COGT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTSLNO
RSI
ODDS (%)
Bullish Trend 4 days ago
79%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
84%
Momentum
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
89%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 19 days ago
85%
Declines
ODDS (%)
Bearish Trend 6 days ago
83%
Bearish Trend 7 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
88%
Aroon
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FUMIX17.560.32
+1.86%
Fidelity SAI US Momentum Index
GSCIX40.780.64
+1.59%
abrdn US Small Cap Equity Inst
ESGEX19.450.27
+1.41%
Reynders McVeigh Core Equity Instl
MEIGX50.030.69
+1.40%
MFS Value R1
HFDCX18.010.20
+1.12%
Hartford Schroders US MidCap Opps C

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
+7.73%
SPHDF - COGT
63%
Loosely correlated
N/A
ENGN - COGT
47%
Loosely correlated
+2.91%
FATE - COGT
40%
Loosely correlated
+2.75%
ARWR - COGT
40%
Loosely correlated
-0.16%
SLNO - COGT
40%
Loosely correlated
+8.51%
More

SLNO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLNO has been loosely correlated with BRNS. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SLNO jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNO
1D Price
Change %
SLNO100%
+8.51%
BRNS - SLNO
56%
Loosely correlated
+4.12%
KANT - SLNO
45%
Loosely correlated
N/A
KYMR - SLNO
43%
Loosely correlated
+3.64%
ACLX - SLNO
41%
Loosely correlated
+5.59%
COGT - SLNO
40%
Loosely correlated
+7.73%
More